Anaphylaxis:
Immunology and Allergy Clinics of North America · 2023-08 · 43 (3) · 467-471
DOI: 10.1016/j.iac.2022.10.008 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Immunology and Allergy Clinics of North America, 2023-08. Verfasst von Nicholas P Gorham. Beteiligte Einrichtung: Ochsner Medical Center, 1514 Jefferson Hwy, New Orleans, LA 70121, USA. Electronic address: Nicholas.Gorham@ochsner.org. Hauptthemen laut MEDLINE: Anaphylaxis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben.
Abstract (Originalsprache)
After treating the acute anaphylactic reaction, the clinician's next task is to prevent a recurrence. The patient should be observed in the ED. How long this observation period should last depends on their clinical course, risk factors, and social support. All patients should be discharged with a prescription for 2 epinephrine autoinjectors and counseled on appropriate use. The patient should also receive education on the signs and symptoms of anaphylaxis and avoiding triggers. The patient should follow-up with an allergy specialist who can confirm triggers and provide immunotherapy as indicated.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Ochsner Medical Center, 1514 Jefferson Hwy, New Orleans, LA 70121, USA. Electronic address: Nicholas.Gorham@ochsner.org.
Zitieren
APA
Gorham, N. P. (2023). Anaphylaxis:. Immunology and Allergy Clinics of North America, 43(3), 467-471. https://doi.org/10.1016/j.iac.2022.10.008
Vancouver
Gorham NP. Anaphylaxis:. Immunology and Allergy Clinics of North America. 2023;43(3):467-471. doi:10.1016/j.iac.2022.10.008
BibTeX
@article{Gorham2023,
author = {Gorham, Nicholas P},
title = {Anaphylaxis:},
journal = {Immunology and Allergy Clinics of North America},
year = {2023},
volume = {43},
number = {3},
pages = {467--471},
doi = {10.1016/j.iac.2022.10.008}
}
EUVIMED